N.J. Admin. Code § 13:39-13.2
"Collaborative drug therapy management" means the cooperative management of a patient's drug, biological, and device-related health care needs, pursuant to a collaborative practice protocol directed on a voluntary basis by a patient's physician with the patient's informed consent, by the patient's physician and a pharmacist who has signed a collaborative practice agreement with the physician.
"Collaborative practice" means that practice of pharmacy whereby one or more pharmacists have jointly agreed to work in conjunction with one or more physicians for the purpose of collaborative drug therapy management of patients, consistent with the requirements of this subchapter.
"Collaborative practice protocol" means a written document that identifies the collaborative drug therapy management actions that a pharmacist is authorized to perform for a patient and that is developed jointly by the pharmacist and the physician and meets the requirements outlined in N.J.A.C. 13:39-13.5.
"Informed consent" means the written document that is signed by a patient whereby the patient agrees to collaborative drug therapy management by the patient's physician and a pharmacist who has entered into a collaborative practice agreement with the physician.
"Therapeutic interchange" means the substitution and dispensing of a drug chemically dissimilar from the prescription drug originally prescribed.
N.J. Admin. Code § 13:39-13.2